Your browser doesn't support javascript.
loading
[Japanese patient preferences between ravulizumab and eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria].
Ishiyama, Ken; Usuki, Kensuke; Ikezoe, Takayuki; Gotoh, Akihiko; Myren, Karl-Johan; Tomazos, Ioannis; Shimono, Akihiko; Ninomiya, Haruhiko; Sakurai, Masatoshi; Nakao, Shinji; Nishimura, Jun-Ichi.
Afiliación
  • Ishiyama K; Department of Hematology, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University.
  • Usuki K; Department of Hematology, NTT Medical Center Tokyo.
  • Ikezoe T; Department of Hematology, Fukushima Medical University.
  • Gotoh A; Department of Hematology, Tokyo Medical University.
  • Myren KJ; Alexion Pharma Nordics AB.
  • Tomazos I; Alexion AstraZeneca Rare Disease.
  • Shimono A; Alexion Pharma G.K.
  • Ninomiya H; Department of Medical Sciences, Faculty of Medicine, University of Tsukuba.
  • Sakurai M; Division of Hematology, Department of Medicine, Keio University School of Medicine.
  • Nakao S; Department of Hematology, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University.
  • Nishimura JI; Department of Hematology and Oncology, Osaka University.
Rinsho Ketsueki ; 64(1): 9-17, 2023.
Article en Ja | MEDLINE | ID: mdl-36775313
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemoglobinuria Paroxística Límite: Adult / Humans Idioma: Ja Revista: Rinsho Ketsueki Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemoglobinuria Paroxística Límite: Adult / Humans Idioma: Ja Revista: Rinsho Ketsueki Año: 2023 Tipo del documento: Article